|
RECK expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.631200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.670000E-01 |
| Normal-vs-Stage2 |
1.140390E-01 |
| Normal-vs-Stage3 |
1.920080E-02 |
| Normal-vs-Stage4 |
6.212100E-02 |
| Stage1-vs-Stage2 |
1.573820E-02 |
| Stage1-vs-Stage3 |
6.24019999999614E-05 |
| Stage1-vs-Stage4 |
8.418400E-03 |
| Stage2-vs-Stage3 |
8.072000E-01 |
| Stage2-vs-Stage4 |
6.643600E-01 |
| Stage3-vs-Stage4 |
7.544200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.972400E-01 |
| Normal-vs-AfricanAmerican |
1.038250E-01 |
| Normal-vs-Asian |
2.996200E-01 |
| Caucasian-vs-AfricanAmerican |
3.044800E-01 |
| Caucasian-vs-Asian |
2.433400E-01 |
| AfricanAmerican-vs-Asian |
1.789620E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.257400E-01 |
| Normal-vs-Female |
8.573200E-01 |
| Male-vs-Female |
2.121000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.846200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.275200E-01 |
| Normal-vs-Age(61-80Yrs) |
7.166200E-02 |
| Normal-vs-Age(81-100Yrs) |
2.006200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.308400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.714000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.925830E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.321600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.758900E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.172800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.879600E-03 |
| Normal-vs-Grade 2 |
3.235600E-01 |
| Normal-vs-Grade 3 |
1.698290E-02 |
| Normal-vs-Grade 4 |
8.657600E-02 |
| Grade 1-vs-Grade 2 |
2.241600E-02 |
| Grade 1-vs-Grade 3 |
2.31719999999047E-05 |
| Grade 1-vs-Grade 4 |
9.195000E-04 |
| Grade 2-vs-Grade 3 |
1.53645999999563E-05 |
| Grade 2-vs-Grade 4 |
1.543750E-02 |
| Grade 3-vs-Grade 4 |
7.242400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.659600E-01 |
| Normal-vs-ccB subtype |
1.510200E-01 |
| ccA subtype-vs-ccB subtype |
2.301600E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.860400E-01 |
| Normal-vs-N1 |
7.325700E-02 |
| N0-vs-N1 |
2.243600E-01 |
|
|
